|

EU101 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Eutilex1

Indications

  • Renal Cell Cancer Metastatic1
  • Renal Cell Carcinoma1
  • Solid Tumor1
  • Prostate Cancer1
  • Lung Cancer1

Philadelphia, Pennsylvania1 trial

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Fox Chase Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.